Financial Times Europe - 27.08.2019

(Grace) #1
Growing role of GHIT
Non-profit pairs
Japanese pharma with
global organisations
Page 2

FT Health


Communicable Diseases


FT SPECIAL REPORT


Tuesday August 27 2019 http://www.ft.com/reports | @ftreports


Inside


Struggle against
superbugs
There are glimmers of
light in the fight against
antimicrobial
resistance
Page 3

Responding to
epidemics
Investing in vaccines
makes strong economic
sense
Page 3

Focus on prevention
Primary care plays
crucial role in fighting
disease
Page 3

O


utside an Ebola treatment
centre in Beni in the Dem-
ocratic Republic of Congo,
medical staff in yellow
smocks, hair nets and blue
surgical gloves administer vaccines to
thefamiliesofhealthworkers.
“You won’t cry will you, Claudi,” a
mother says to her small son, as the
nurse plunges the life-saving vaccine
intohisleftarm.
The shot, developed by Merck, the US
pharmaceutical company, has been a
revelation. Though still unlicensed, the
vaccine has demonstrated an estimated
efficacy of 97.5 per cent in stopping
infection for the haemorrhagic fever
that was impossible to prevent as
recentlyas2014.
But it has not been enough. Despite
the vaccination of more than 180,
people, Ebola is still spreading more
than 12 months after the first cases in
thislatestoutbreakwereidentified.
This has stoked a heated debate over
the medical response, the ethics of vac-
cination trials and why a second experi-
mental vaccine developed by Johnson &
Johnson is still languishing in Dutch
warehouses.

Pharmacists first trialled the Merck
vaccine, rVSV-ZEBOV, on 16,000 volun-
teers during the 2014-2016 Ebola epi-
demic in west Africa that killed more
than 11,000 people. Despite dozens of
outbreaks since the virus was first iden-
tified in the forests of central Congo in
1976, progress to develop and test a

potential vaccine was slow.
When the current crisis started a year
ago, Congolese officials agreed to a more
expansive trial of the Merck product
under global “compassionate use” pro-
tocols, which allow for unlicensed treat-
ments to be administered when there is
nobetteralternative.

The trial has used a “ring vaccination”
strategy, where the circle of people with
whom an infected patient has come into
contact, in addition to the circle of peo-
ple around each contact, receive the
vaccine. Frontline health professionals
also received the shot. In the first eight
months of the outbreak, each ring aver-

Vaccine debate dogs Ebola response


Vaccination strategies


for curbing the latest


outbreak in DRC are


fiercely contested,


writesTom Wilson


aged just over 100 people, according to
theWHO.
The trial has been successful,
the WHO says, delivering immunity
in more than 97 per cent of cases — but
it has not stopped the outbreak.
Anne-Marie Pegg, a doctor with the
Continued on page 2

Family members of a deceased Ebola victim get to see the body before burial in Beni last month. Almost 2,000 have died in the current outbreak— John Wessels/FT

Public health experts in the US are try-
ing to beat “anti-vaxxers” at their own
game by using new tactics to stem the
spread of misinformation about vac-
cines, as the country suffers its largest
measlesoutbreakin27years.
So far this year, more than a thousand
Americans have contracted measles — a
childhoodinfectionthatcanleadtohos-
pitalisation and death — as unvacci-
nated travellers bring back the disease
once thought to have been eliminated
byvaccines.
Local authorities have tried to boost
vaccination rates by removing exemp-
tionsthatallowparentstoputtheirchil-
dren in school without having shots.
New York City introduced a $1,000 fine
for those who did not vaccinate in the
middleofanoutbreakinaJewishOrtho-
doxneighbourhoodinBrooklyn.
Butmostrealisethatrulesandregula-
tions cannot win in an information war.
Vaccination levels have slipped because
of concerted campaigns to spread
rumours on social media that they are
unsafe — fuelled by distrust of govern-
ment and scientific expertise. Instead,
public health authorities are trying to
hone how they communicate with anx-
ious parents, whose fears may have
beenignitedbydisinformationonline.
Brad Hutton, the deputy commis-
sioner at New York state’s office of pub-
lic health — which co-ordinated the
response to a separate outbreak this
yearinRocklandCounty—saysthatone
misconception is that measles is not
serious. “People have forgotten that in
prior generations as many as one in four
childrenwithmeasleswashospitalised,”
hesays.
As anti-vaxxers stir up fears that vac-
cines can give children autism, public
health experts believe it is important to
counter with tragic tales of people who
sufferedfrompreventablediseases.
In Denmark and Ireland, for instance,
officials tackled concerns about giving
young girls the vaccine against HPV —
human papillomavirus — with social

media testimonials from people who
had lost wives or mothers to cervical
cancer.
The messenger and the style of deliv-
ery are just as important as the message
itself. Jennifer Nuzzo, senior scholar at
the Johns Hopkins Center for Health
Security, says it is important to segment
your audience and understand that not
everyone is “vaccine-hesitant” for the
same reasons. “You can’t treat this
group as a monolith, you really have to
understand the underlying motivation
andaddressit,”shesays.
In some cases, it can be as simple as
improving access to vaccines, or tack-
ling concerns about having too many at
once. Some might be worried that vac-
cines are not “natural” and believe they
can tackle diseases with a healthy life-
style, while others may resist because
theydonotlikebeingtoldwhattodo.
Many healthcare professionals are
adopting a “presumptive approach”,
where instead of asking parents if they
want vaccines, they presume they do.
Theytellparentsitisimportant,backed
by scientific evidence, and safe, giving
themlessroomtopullout.
But in Quebec, Canada, they are
experimenting with a very different
technique called “motivational inter-
viewing”, designed to help parents feel
their concerns are understood. Instead
of confronting misinformation head on
— and potentially causing ambushed
parents to dig their heels in — they ask
questions to encourage them to exam-
inetheirownuncertainties.
Thatprojectisalsotryingtomeetpar-
ents earlier. “We deploy education in

maternity wards across Quebec to
encourage parents to get vaccinated
when the babies are born,” says Dr
Theresa Tam, Canada’s chief public
health officer. “We borrow from behav-
ioural science to provide a technique
that allows the provider to communi-
cateinthemosteffectiveway.”
Another important technique is to
help people understand the tools anti-
vaxxers are using to manipulate them,
such as fake experts, Dr Tam says.
“Never underestimate the fact that peo-
pledowanttohavefacts,”sheadds.
Parents may want the facts — but
often the last place they go is to their
public health agency. Facebook and
Twitter are trying to change this, by
putting a link to each country’s author-
ity first in the rankings when people
searchforvaccinesontheirsites.
Sending messages from on high is one
thing, but getting people from the com-
munity to inform others can be more
effective. In Rockland County, New
York state worked with local religious
leaders and healthcare centres. In Can-
ada, the state is getting “parenting influ-
encers” — who already have large audi-
ences of young parents — to spread the
messageonline.
The London School of Hygiene and
Tropical Medicine’s Vaccine Confidence
Projectmonitorsmisinformationonline
in real time, operating a “triage”
approach where local health officials
around the world are alerted to emerg-
ingissues.
Professor Heidi Larson, who runs the
project, says social media sites have to
be wary of being perceived to be delet-
inginformation.“Itcouldleadtoaback-
lash as it absolutely pushes that button
that‘theyarecensoringus’,”shesays.
Pro-vaccine campaigners also need to
be wary of using language that alienates
their audience. She said some people
who were just asking responsible
parenting questions could feel “demon-
ised” by the language used by those in
favourofvaccinesonline.
So far, there is no perfect protocol for
publichealthofficialstocombatvaccine
misinformation. Ms Nuzzo says she
wouldlovetosee“moreintellectualfire-
power” — including from behavioural
economics — to inform the experiments
to boost vaccination rates. With hard
workandoutsideexpertise,shebelieves
society has shown it can change its atti-
tudes.“Itrulybelieveitisafixableprob-
lem,”shesays.

Officials give ‘anti-vaxxers’


taste of their own medicine


Measles


US public health authorities
use social media and
influencers to curb spread of
disinformation.Hannah
Kuchlerreports

New York nurse prepares a vaccine

AUGUST 27 2019 Section:Reports Time: 23/8/2019 - 17: 52 User: darren.dodd Page Name: CMD1, Part,Page,Edition: CMD, 1 , 1


RELEASED BY "What's News"


vk.com/wsnws

TELEGRAM: t.me/whatsnws
Free download pdf